Zurich Pharma Inc
FDA import alert and refusal historyWindsor, CanadaFEI 3011799128
As of October 26, 2026, Zurich Pharma Inc is not on any FDA import alert in SupplierRadar's records; FDA refused 8 of its shipment lines between January 26, 2018 and April 1, 2022, most often for no u.s. adverse event contact on supplement label (NCONTACT).
Data from FDA public records, last checked . Request a correction
Current status
- Import alerts
- Not listed
- Last import refusal
- Vitamin, mineral, proteins and unconventional dietary specialities for humans and animals, n.e.c. · UNAPPROVED
- Last warning letter
- None found
- Last inspection
- None on record
Every FDA record for Zurich Pharma Inc
8 records, newest first. Each line links to the FDA page it came from.
2022
- Import refusalRefused, Vitamin, mineral, proteins and unconventional dietary specialities for humans and animals, n.e.c.UNAPPROVEDEntry 300-2954350-1Source
- Import refusalRefused, Vitamin b12 (cyanocobalamin)LABELINGEntry 300-2925437-2Source
2018
- Import refusalRefused, Royal jelly (vit/min/protein/unconventional dietary spec for human/animal, n.e.c.)NCONTACTUNAPPROVEDEntry UPS-7127375-0Source
- Import refusalSource
Refused, 2 lines in one entry: Vitamin, mineral, proteins and unconventional dietary specialities for humans and animals, n.e.c.DIETARYLBLNCONTACTLABELINGDIETARYINGEntry 300-1177388-4Show 2 linesHide lines
- Refused, Vitamin, mineral, proteins and unconventional dietary specialities for humans and animals, n.e.c.DIETARYLBLNCONTACTLABELINGEntry 300-1177388-4Source
- Refused, Vitamin, mineral, proteins and unconventional dietary specialities for humans and animals, n.e.c.DIETARYINGNCONTACTLABELINGEntry 300-1177388-4Source
- Import refusalRefused, Royal jelly (vit/min/protein/unconventional dietary spec for human/animal, n.e.c.)NCONTACTUNAPPROVEDEntry UPS-7219232-2Source
- Import refusalRefused, Royal jelly (vit/min/protein/unconventional dietary spec for human/animal, n.e.c.)NCONTACTUNAPPROVEDEntry UPS-7138104-1Source
- Import refusalRefused, Royal jelly (vit/min/protein/unconventional dietary spec for human/animal, n.e.c.)NCONTACTUNAPPROVEDEntry UPS-7127418-8Source
Refusal charges, in plain English
- NCONTACT6 refused lines
No U.S. adverse event contact on supplement label
The dietary supplement label appeared not to show a U.S. address or phone number through which a serious adverse event can be reported.
- UNAPPROVED5 refused lines
Unapproved new drug
The product appeared to be a new drug within the meaning of section 201(p) of the FD&C Act without an approved New Drug Application. FDA can apply this charge to a food or supplement whose labeling presents it for drug uses.
- LABELING3 refused lines
Fair Packaging and Labeling Act
The package appeared not to meet the Fair Packaging and Labeling Act because of the placement, form, or contents of a required label statement.
- DIETARYING1 refused line
Dietary ingredients not listed
The dietary supplement label appeared not to list each dietary ingredient and its quantity, or the total quantity of a proprietary blend.
- DIETARYLBL1 refused line
Not identified as a dietary supplement
The label appeared not to identify the product with the term "dietary supplement" (which may be modified with the name of an ingredient).
Questions about Zurich Pharma Inc
- Is Zurich Pharma Inc on an FDA import alert?
- No listing for Zurich Pharma Inc appears in the FDA import alerts SupplierRadar checked on October 26, 2026. Country-wide alerts may still apply to its products; see the Canada page.
- Has FDA refused shipments from Zurich Pharma Inc?
- Yes. FDA refused 8 shipment lines from Zurich Pharma Inc between January 26, 2018 and April 1, 2022. The most recent, on April 1, 2022, was vitamin, mineral, proteins and unconventional dietary specialities for humans and animals, n.e.c., charged as UNAPPROVED (unapproved new drug).
- Why did FDA refuse Zurich Pharma Inc's shipments?
- The most frequent charges are NCONTACT (no u.s. adverse event contact on supplement label, 6 lines) and UNAPPROVED (unapproved new drug, 5 lines).
- What is Zurich Pharma Inc's FEI number?
- Zurich Pharma Inc's FDA Establishment Identifier (FEI) is 3011799128.
Buying from Zurich Pharma Inc?
Watch it and get the FDA record the day it changes. Free for one supplier.
SupplierRadar is not affiliated with the U.S. Food and Drug Administration. Data comes from public FDA records and may contain errors. This is not legal advice; importers remain responsible for their supplier evaluations.